As of November 2024, TaiGen Biopharmaceuticals Holdings has a market cap of $326.57M. This makes TaiGen Biopharmaceuticals Holdings the world's 14148th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $338.91M | -0.66% |
2023 | $341.16M | -5.30% |
2022 | $360.23M | 4.22% |
2021 | $345.64M | -32.60% |
2020 | $512.86M | 24.18% |
2019 | $412.98M | 8.24% |
2018 | $381.56M | -21.66% |
2017 | $487.05M | -20.22% |
2016 | $610.49M | -19.53% |
2015 | $758.65M | -12.29% |
2014 | $864.95M | -42.67% |
2013 | $1.51B | - |